Akebia Therapeutics | AKBA - 资产



金融业
股票价格
USD
资产
USD 349.66M
现金及等价物
USD 155.55M
销售成本
USD 10.34M
流动资产
USD 229.55M
流动负债
USD 160.87M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 25.02M
销售毛利
USD 47.28M
债务利息支出
349.66M
贷款资金
USD 24.75M
市值
USD 192.3M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13.02M
贸易债权人
USD 9.42M
应收帐款人
USD 47.03M


资产 更改 日
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics USD 349.66M 12.86M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amgen USD 95.64B 3.14B 2026-06
Ardelyx USD 504.51M 2.9M 2026-03
Astellas Pharma JPY 3.69T 125.48B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.29B 659M 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Celltrion KRW 768.81B 9.37B 2026-03
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Exelixis USD 2.49B 99.36M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
J&J USD 201.06B 167M 2026-06
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 10.96B 527M 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 2.07M 414K 2025-12
Pharma Mar EUR 393.6M 8.34M 2026-06
Prothena USD 302.58M 47.32M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Qiagen NV USD 5.89B 107.14M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Tilray USD 2.1B 15.95M 2025-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03